Chronic pain management is at a tipping point. With millions suffering from TMJ dysfunction and chronic anterior knee pain, the global healthcare system is desperate for non-opioid, non-invasive alternatives to surgery.
To learn more visit www.coneymedical.com
Required Regulation A Disclaimer for Marketing Materials
Regulation A Testing the Waters Disclosure
No money or other consideration is being solicited, and if sent in response, it will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the Securities and Exchange Commission has been qualified. Any indication of interest in response to this communication involves no obligation or commitment of any kind.
A potential investor’s indication of interest is non-binding. Any offering of securities will be made only through an Offering Circular that forms a part of the qualified Offering Statement. Before investing, you should carefully review the Offering Circular, including the Risk Factors section, and the other documents the issuer has filed with the Securities and Exchange Commission.
Forward-Looking Statements
This communication may contain forward-looking statements that are based on current expectations and assumptions. Actual results may differ materially. Neither the SEC nor any state securities regulator has approved or disapproved of the securities or determined whether this communication is truthful or complete.
State (Blue Sky) Notice
The securities referenced in a Regulation A offering may be offered and sold only in states where they are permitted under applicable Blue Sky laws. Qualification by the SEC does not imply approval by any state securities regulator.
IMPORTANT LEGAL DISCLOSURE: REGULATION D, RULE 506(c) OFFERING
This offering is a private placement of securities pursuant to Rule 506(c) of Regulation D under the Securities Act of 1933, as amended. The following conditions strictly apply:
- Accredited Investors Only: All securities offered by the Blue Thunder Fund are available only to Accredited Investors as defined by Rule 501 of Regulation D.
- Mandatory Verification: The Issuer is required to, and will, take reasonable steps to verify the accredited status of every purchaser. Your self-certification is insufficient. You will be required to provide evidence of your accredited status (e.g., income verification or professional certifications) before your investment can be finalized.
- General Solicitation: Due to the use of Rule 506(c), the Fund engages in general solicitation and advertising, including this website.
- Risk Disclosure: Investment in the Blue Thunder Fund involves a high degree of risk, is speculative, and is suitable only for accredited investors who can bear the entire risk of the loss of their investment. The securities have not been registered under the Securities Act of 1933, as amended, or any state securities laws.
Review of the Private Placement Memorandum (PPM) is required prior to any investment decision.
